Autologous CRISPR-Cas9 engineered regnase-1/SOCS1 dual-edited tumor infiltrating lymphocytes KSQ-004EX
Term · Oncology and biomedicine · MLC-T-ONC-011581
A preparation of autologous tumor infiltrating lymphocytes (TILs) gene-edited with the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 nuclease complex to inactivate both the endogenous genes suppressor of cytokine signaling 1 (SOCS1) and Regnase-1, with potential immunomodulating and antineoplastic activities. Upon infusion of the autologous CRISPR-Cas9 engineered Regnase-1/SOCS1 dual-edited TILs KSQ-004EX back into the patient, the cells specifically recognize, target and kill the patient's tumor cells. Inactivation of endogenous SOCS1 and Regnase-1 in the TILs increases responsiveness to cytokine signals, increases persistence and memory formation of TILs, and enhances anti-tumor responses.
| Identifier | MLC-T-ONC-011581 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous CRISPR-Cas9 engineered TILs KSQ-004EX; autologous dual-edit eTILs KSQ-004EX; autologous engineered tumor infiltrating lymphocytes KSQ-004EX; autologous eTILs KSQ-004EX; autologous SOCS1/regnase-1 inactivated engineered TILs KSQ-004EX; autologous SOCS1/Regnase-1-edited TILs KSQ-004EX; CRISPR/Cas9-edited SOCS1/Regnase-1 gene-inactivated autologous TILs KSQ-004EX; Regnase-1/SOCS1 dual-edited human CRISPR/Cas9-engineered TILs KSQ-004EX |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011581",
"term": "Autologous CRISPR-Cas9 engineered regnase-1/SOCS1 dual-edited tumor infiltrating lymphocytes KSQ-004EX",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous tumor infiltrating lymphocytes (TILs) gene-edited with the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 nuclease complex to inactivate both the endogenous genes suppressor of cytokine signaling 1 (SOCS1) and Regnase-1, with potential immunomodulating and antineoplastic activities. Upon infusion of the autologous CRISPR-Cas9 engineered Regnase-1/SOCS1 dual-edited TILs KSQ-004EX back into the patient, the cells specifically recognize, target and kill the patient's tumor cells. Inactivation of endogenous SOCS1 and Regnase-1 in the TILs increases responsiveness to cytokine signals, increases persistence and memory formation of TILs, and enhances anti-tumor responses.",
"synonyms": [
"autologous CRISPR-Cas9 engineered TILs KSQ-004EX",
"autologous dual-edit eTILs KSQ-004EX",
"autologous engineered tumor infiltrating lymphocytes KSQ-004EX",
"autologous eTILs KSQ-004EX",
"autologous SOCS1/regnase-1 inactivated engineered TILs KSQ-004EX",
"autologous SOCS1/Regnase-1-edited TILs KSQ-004EX",
"CRISPR/Cas9-edited SOCS1/Regnase-1 gene-inactivated autologous TILs KSQ-004EX",
"Regnase-1/SOCS1 dual-edited human CRISPR/Cas9-engineered TILs KSQ-004EX"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-crispr-cas9-engineered-regnase-1-socs1-dual-edited-tumor-infiltrating/"
}
Record 2,915 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.